Drug profile · INN
naldemedine
RIZMOIC
naldemedine (RIZMOIC) is a mu opioid receptor antagonist.
EMA: approved Alimentary tract and metabolism (A06) A06AH05
Patents linked 0
Pipeline programs 0
News articles 1
Drug details — naldemedine
- Class
- Alimentary tract and metabolism (A06)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
naldemedine (RIZMOIC) is a mu opioid receptor antagonist.
Key facts
INN naldemedine
Brand RIZMOIC
Mechanism Mu opioid receptor antagonist
Target Mu-type opioid receptor
Therapeutic class Alimentary tract and metabolism (A06)
ATC code A06AH05
Mechanism of action
Mu opioid receptor antagonist
Primary target: Mu-type opioid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Recent coverage
Related & competitor drugs
Frequently asked questions
What is naldemedine?
naldemedine (RIZMOIC) is a mu opioid receptor antagonist.
What is the brand name for naldemedine?
RIZMOIC is a marketed brand name for naldemedine. Check FDA Drugs@FDA for the current US label holder and prescribing information.